The EU has recommended lenacapavir, an injectable drug for HIV prevention, which could drastically reduce transmission rates. With nearly 100% effectiveness, it promises a new era in combating HIV.
The European Medicines Agency has recommended the approval of lenacapavir, a twice-yearly injectable drug that could revolutionize HIV prevention and significantly reduce transmission rates globally.
The WHO has issued a critical alert about a potential chikungunya virus epidemic, reminiscent of the major outbreak 20 years ago. With over 5.6 billion people at risk, they urge immediate action to prevent a repeat of history.
A staggering 14 million children worldwide have not received any vaccines, exacerbated by conflict, misinformation, and funding cuts. Experts urge immediate action to protect vulnerable populations.
The UNAIDS annual report warns that decades of progress in combating HIV/AIDS are jeopardized by significant funding cuts, particularly from U.S. donors, threatening millions of lives in the coming years.
Recent U.S. funding cuts to AIDS programs have sparked alarms, with UNAIDS warning of potential catastrophic rises in HIV infections and AIDS-related deaths. The future of global health hangs in the balance.
In a groundbreaking move, Novartis has received approval for Coartem® Baby, the first malaria treatment specifically designed for newborns and young infants, addressing a critical healthcare gap in malaria-endemic regions.
Swiss authorities have approved Coartem Baby, the first malaria treatment for newborns under 11 pounds, addressing a significant health gap for vulnerable infants. This sweet cherry-flavored drug can be mixed with breast milk, making it easier to administer.
A new study reveals that vaccination efforts for children worldwide have stalled, putting millions at risk for preventable diseases. The impact of the pandemic and vaccine misinformation are key factors in this concerning trend.
The FDA has approved lenacapavir, a groundbreaking antiviral drug for HIV prevention developed by biochemist Wesley Sundquist. Learn how this drug could change the future of HIV treatment and prevention.
